Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

Delaying the study results for almost three weeks was a dumb move by management.

Why would they kill the upward momentum by doing so?

Possibly the results weren't as good as expected?

If the results are positive why not say so and then state that the Med-Forum presentation would focus on how the company intended to commercialize the MANF technology going forward. That approach would have this at a much higher price today.

"Stupid is as stupid does."

Rainbow Coral Corporation is a joke. Check it out.